Concepedia

Author

Shola Adeyemi

Institut Gustave RoussyORCID

Also Known As

S Adeyemi, S O Adeyemi, S. Adeyemi, Shola Adeyemi

42

Publications

353

Citations

9

H-Index

25

Concepts

All Affiliations

Institut Gustave RoussyNational Cancer Center Hospital EastHarvard UniversityHôpital Louis PradelWestern Health
SA

About

Shola Adeyemi is an author at Institut Gustave Roussy specializing in medicine, surgical oncology, and radiologic imaging.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

48

2

Health Sciences

1

1

15

3

Nursing

1

1

33

4

Public Health

1

1

33

5

Emergency Medicine

1

1

33

Shola Adeyemi

×

9

Publications

257

Citations

9

H-Index

YearCitations

Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive Cancer

Alison M. Schram, Kōichi Goto, Dong-Wan Kim,

New England Journal of Medicine

2025

78

Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial

Benjamin Garlipp, Peter Gibbs, Guy A. Van Hazel,

British journal of surgery

2019

46

Towards an evidence-based decision making healthcare system management: Modelling patient pathways to improve clinical outcomes

Shola Adeyemi, Eren Demir, Thierry Chaussalet

Decision Support Systems

2013

33

Modelling length of stay and patient flows: methodological case studies from the UK neonatal care services

Eren Demir, Reda Lebcir, Shola Adeyemi

Journal of the Operational Research Society

2013

24

Polypharmacy in psychiatric outpatient practice in northern Nigeria

Ademola Adeponle, Abiodun Obembe, Shola Adeyemi,

African Journal of Psychiatry

2008

23

Efficacy and safety of co‐crystal of tramadol‐celecoxib (<scp>CTC</scp>) in acute moderate‐to‐severe pain after abdominal hysterectomy: A randomized, double‐blind, phase 3 trial (<scp>STARDOM2</scp>)

R. M. Langford, Adelaida Morte, Mariano Sust,

European Journal of Pain

2022

18

REsect: Blinded assessment of amenability to potentially curative treatment of previously unresectable colorectal cancer liver metastases (CRC LM) after chemotherapy ± RadioEmbolization (SIRT) in the randomized SIRFLOX trial.

Benjamin Garlipp, Peter Gibbs, Guy A. Van Hazel,

Journal of Clinical Oncology

2017

15

1315MO Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)

Alison M. Schram, Kōichi Goto, Dongwook Kim,

Annals of Oncology

2023

10

Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)

R. M. Langford, Esther Pogatzki‐Zahn, Adelaida Morte,

Advances in Therapy

2024

10

Page 1